For example, the research of Grossberg et al. (Grossberg et al., 2021) showed that the antibody levels of S1-RBD IgA, NP IgG, and S2 IgA can be used to identify severe, mild, and asymptomatic groups of COVID-19 patients. This evidence concerns the gene CD79A and COVID-19.